Steripharma

Steri-Pharma is a private, commercial-stage biopharmaceutical company focused on the production and global supply of sterile injectable antibiotics. Operating from San Diego, the company emphasizes manufacturing discipline, quality control, and reliability as its key competitive advantages in the generic sterile injectables market. While not a drug developer, it serves as a critical manufacturer within the pharmaceutical supply chain, addressing ongoing needs in anti-infective therapeutics. Its business model is centered on manufacturing and sales, targeting both developed and emerging international markets.

Advanced sterile manufacturing and aseptic fill-finish processes for injectable small-molecule antibiotics, emphasizing rigorous quality assurance and regulatory compliance.

Steri-Pharma competes in the crowded generic sterile injectables market against large multinational generics manufacturers (e.g., Pfizer/Hospira, Fresenius Kabi, Hikma) and other specialized CDMOs. Its differentiation is claimed through a singular focus on antibiotic quality and reliability, rather than scale or breadth of portfolio.